HAII Secures MFDS Approval for Confirmatory Clinical Trials of Dementia Diagnostic Digital Device
HAII becomes the first in South Korea to receive MFDS approval for clinical trials of its diagnostic digital device, Alzguard, which uses digital biomarkers like voice, eye movement, and cognitive response for early detection.
@Copyright 2022. All Right Reserved. Hosted by Imweb